Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease

Neurobiology of Aging

Volumn 27, Issue 11, 2006, Pages 1537-1553

  D'Introno, Alessia ^a   Solfrizzi, Vincenzo ^a   Colacicco, Anna Maria ^a   Capurso, Cristiano ^b   Amodio, Margherita ^a   Todarello, Orlando ^a   Capurso, Antonio ^a   Kehoe, Patrick G ^c   Panza, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alpha 2 macroglobulin; Alzheimer's disease; Association; Chromosome 12; Linkage; Low density lipoprotein receptor related protein 1; Oxidised LDL receptor 1; Transcription factor LBP 1c CP2 LSF

Indexed keywords

ALPHA 2 MACROGLOBULIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ALZHEIMER DISEASE; CHROMOSOME 12; CHROMOSOME ARM; GENE FUNCTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN GENOME; ONSET AGE; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LINKAGE DISEQUILIBRIUM; RECEPTORS, LDL; TELOMERE; TRANSCRIPTION FACTORS;

EID: 33748573310     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.09.020     Document Type: Review

References (156)

1. Alvarez V., Alvarez R., Lahoz C.H., Martinez C., Pena J., Guisasola L.M., et al. Association between an alpha[2] macroglobulin DNA polymorphism and late-onset Alzheimer's disease. Biochem Biophys Res Commun 264 (1999) 48-50
2. Arelin K., Kinoshita A., Whelan C.M., Irizarry M.C., Rebeck G.W., Strickland, et al. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes. Brain Res Mol Brain Res 104 (2002) 38-46
3. Bagli M., Papassotiropoulos A., Jessen F., Schmitz S., Rao M.L., Maier W., et al. Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population. Am J Med Genet 96 (2000) 775-777
4. Baum L., Chen L., Ng H.K., Chan Y.S., Mak Y.T., Woo J., et al. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 247 (1998) 33-36
5. Beffert U., Arguin C., and Poirier J. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease. Neurosci Lett 259 (1999) 29-32
6. Bertram L, McQueen M, Mullin K, Blacker D, Tanzi R. The AlzGene Database. Alzheimer Research Forum. Available at: http://www.alzgene.org.
7. Bertram L., Blacker D., Crystal A., Mullin K., Keeney D., Jones J., et al. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family based methodologies. Exp Gerontol 35 (2000) 1353-1361
8. Bertram L., Parkinson M., Mullin K., Menon R., Blacker D., and Tanzi R.E. No association between a previously reported OLR1 3′-UTR polymorphism and Alzheimer's disease in a large family sample. J Med Gen 41 (2004) 286-288
9. Bi S., Zhang Y., Wu J., Wang D., and Zhao Q. Association between low-density lipoprotein receptor-related protein gene, butyrylcholinesterase gene and Alzheimer' s disease in Chinese. Chin Med Sci J 16 (2001) 71-75
10. Bing Z., Reddy S.A., Ren Y., Qin J., and Liao W.S. Purification and characterization of the serum amyloid A3 enhancer factor. J Biol Chem 274 (1999) 24649-24656
11. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19 (1998) 357-360
12. Blacker D., Crystal A.S., Wilcox M.A., Laird N.M., and Tanzi R.E. In reply. Nat Genet 22 (1999) 21-22
13. Blacker D., Bertram L., Saunders A.J., Moscarillo T.J., Albert M.S., Wiener H., and NIMH Genetics Initiative Alzheimer's Disease Study Group. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12 (2003) 23-32
14. Blennow K., Ricksten A., Prince J.A., Brookes A.J., Emahazion T., Wasslavik C., et al. No association between the alpha2-macroglobulin [A2M] deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm 107 (2000) 1065-1079
15. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6 (1992) 3345-3353
16. Bullido M.J., Guallar-Castillon P., Artiga M.J., Ramos M.C., Sastre I., and Aldudo J. Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender. Neurosci Lett 289 (2000) 213-216
17. Bullido M.J., Ramos M.C., Ruiz-Gomez A., Tutor A.S., Sastre I., Frank A., et al. Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's. Neurobiol Aging 25 (2004) 853-859
18. Cai L., Tang G., Chen L., Zhang B., Jiang S., and Ren D. Genetic studies of A2M and BACE1 genes in Chinese Han Alzheimer's disease patients. Neuroreport 16 (2005) 1023-1026
19. Camelo D., Arboleda G., Yunis J.J., Pardo R., Arango G., Solano E., et al. Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients. J Neurol Sci 218 (2004) 47-51
20. Cataldo A.M., Barnett J.L., Pieroni C., and Nixon R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased β-Amyloidogenesis. J Neurosci 17 (1997) 6142-6151
21. Causevic M., Ramoz N., Haroutunian V., Davis K.L., and Buxbaum J.D. Lack of association between the levels of the low-density lipoprotein receptor-related protein [LRP] and either Alzheimer dementia or LRP exon 3 genotype. J Neuropathol Exp Neurol 62 (2003) 999-1005
22. Chen L., Baum L., Ng H.K., Chan L.Y., Sastre I., Artiga M.J., et al. Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease. Neurosci Lett 269 (1999) 173-177
23. Chen D., Zhang J.W., Zhang Z.X., Wu Y.N., and Qu Q.M. Association of alpha 2-macroglobulin polymorphisms and Alzheimer disease in Mainland Han Chinese. J Neurol Sci 217 (2004) 13-15
24. Clarimon J., Bertranpetit J., Calafell F., Boada M., Tarraga L., and Comas D. Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population. Psychiatric Genet 13 (2003) 85-90
25. Clatworthy A.E., Gomez-Isla T., Rebeck G.W., Wallace R.B., and Hyman B.T. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch Neurol 54 (1997) 1289-1292
26. Combarros O., Infante J., Llorca J., Pena N., Fernandez-Viadero C., and Berciano J. Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk. J Neurol 252 (2005) 485-487
27. Cominacini L., Rigoni A., Pasini A.F., Garbin U., Davoli A., Campagnola M., et al. The binding of oxidized low density lipoprotein [ox-LDL] to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 276 (2001) 13750-13755
28. Corder E.H., Robertson K., Lannfelt L., Bogdanovic N., Eggertsen G., Wilkins J., et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4 (1998) 1182-1184
29. Crawford F., Town T., Freeman M., Schinka J., Gold M., Duara R., et al. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample. Neurosci Lett 270 (1999) 133-136
30. Christensen M.A., Zhou W., Qing H., Lehman A., Philipsen S., and Song W. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol Cell Biol 24 (2004) 865-874
31. Curtain C.C., Ali F.E., Smith D.G., Bush A.I., Masters C.L., and Barnham K.J. Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid. J Biol Chem 278 (2003) 2977-2982
32. Dabrowski C.E., Carmillo P.J., and Schaffer P.A. Cellular protein interactions with herpes simplex virus type 1 oriS. Mol Cell Biol 14 (1994) 2355-2545
33. Dodel R.C., Du Y., Bales K.R., Gao F., Eastwood B., Glazier B., et al. Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology 54 (2000) 438-442
34. Dow D.J., Lindsey N., Cairns N.J., Brayne C., Robinson D., Huppert F.A., et al. Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet 22 (1999) 16-17 [author reply 21-2]
35. Du Y., Bales K.R., Dodel R.C., Liu X., Glinn M.A., Horn J.W., et al. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 70 (1998) 1182-1188
36. D'Introno A., Solfrizzi V., Colacicco A.M., Capurso C., Torres F., Capurso S.A., et al. Polymorphisms in oxidised low-density lipoprotein receptor-1 [OLR1] gene and risk of Alzheimer's disease. J Gerontol A: Med Sci Biol Sci 60 (2005) 280-284
37. Eikelenboom P., and van Gool W.A. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm 111 (2004) 281-294
38. Emahazion T., Feuk L., Jobs M., Sawyer S.L., Fredman D., St Clair D., et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 17 (2001) 407-413
39. Fallin D., Kundtz A., Town T., Gauntlett A.C., Duara R., Barker W., et al. No association between the low density lipoprotein receptor-related protein [LRP] gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett 233 (1997) 145-147
40. Farrer L.A., Bowirrat A., Friedland R.P., Waraska K., Korczyn A.D., and Baldwin C.T. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet 12 (2003) 415-422
41. Gaynor R.B., Shieh B.-H., Klisak I., Sparkes R.S., and Lusis A.J. Localization of the transcription factor SP1 gene to human chromosome 12q12-q13.2. Cytogenet Cell Genet 64 (1993) 210-212
42. Gibson A.M., Singleton A.B., Smith G., Woodward R., McKeith I.G., Perry R.H., et al. Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology 54 (2000) 433-438
43. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
44. Gutala R.V., and Reddy P.H. The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J Neurosci Meth 132 (2004) 101-107
45. Halimi G., Duplan L., Bideau C., Iniesta D., Berthezene P., Oddoze C., et al. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease. Neuroreport 11 (2000) 3599-3601
46. Hardy J. The real problem in association studies. Am J Med Genet 114 (2002) 253
47. Harris M., Sanghera D.K., and Kamboh M.I. Short report on DNA marker at candidate locus. Two new alleles in the tetranucleotide repeat polymorphism in the LDL-receptor-related protein (LRP) gene. Clin Genet 50 (1996) 54-55
48. Hatanaka Y., Kamino K., Fukuo K., Mitsuda N., Nishiwaki-Ueda Y., Sato N., et al. Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population. Clin Genet 58 (2000) 319-323
49. Herz J., and Strickland D.K. LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108 (2001) 779-784
50. Higuchi S., Matsushita S., Nakane J., Arai H., Matsui T., Urakami K., et al. Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease. Neuroreport 11 (2000) 1167-1171
51. Hollenbach E., Ackermann S., Hyman B.T., and Rebeck G.W. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 50 (1998) 1905-1907
52. Holmans P., Myers A., Hardy J., Goate A., Williams J., and Owen M. Evidence of interaction between susceptibility loci on chromosomes 1, 10 and 12 in late-onset Alzheimer's disease [LOAD]. Am J Hum Genet 73 Suppl (2003) 471 [Abstract]
53. Hu C.J., Sung S.M., Liu H.C., Lee K.Y., Hsu W.C., Wong W.K., et al. No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese. Neurology 53 (1999) 642-643
54. Hu C.J., Sung S.M., Liu H.C., Hsu W.C., Lee L.S., Lee C.C., et al. Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan. J Neurol Sci 181 (2000) 127-131
55. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., et al. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 95 (1998) 3275-3280
56. Imanishi T., Hano T., Sawamura T., Takarada S., and Nishio I. Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Circ J 66 (2002) 1060-1064
57. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
58. Itzhaki R.F., Lin W.R., Wilcock G.K., and Faragher B. HSV-1 and risk of Alzheimer's disease. Lancet 352 (1998) 238
59. Jamieson S.E., White J.K., Howson J.M., Pask R., Smith A.N., Brayne C., et al. Candidate gene association study of solute carrier family 11a members 1 [SLC11A1] and 2 (SLC11A2) genes in Alzheimer's disease. Neurosci Lett 374 (2005) 124-128
60. Janka Z., Juhasz A., Rimanoczy A., Boda K., Marki-Zay J., Palotas M., et al. Alpha2-macroglobulin exon 24 [Val-1000-Ile] polymorphism is not associated with late-onset sporadic Alzheimer's dementia in the Hungarian population. Psychiatric Genet 12 (2002) 49-54
61. Jhoo J.H., Kim K.W., Lee D.Y., Lee K.U., Lee J.H., Kim S.Y., et al. Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. J Neurol Sci 184 (2001) 21-25
62. Kabbara A., Payet N., Cottel D., Frigard B., Amouyel P., and Lambert J.C. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett 363 (2004) 139-143
63. Kamboh M.I., Ferrell R.E., and DeKosky S.T. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett 244 (1998) 65-68
64. Kamboh M.I. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 68 (2004) 381-404
65. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., et al. Genetic association of the low density lipoprotein receptor-related protein gene [LRP], an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49 (1997) 56-61
66. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W.S., Holmans P., Fenton I., et al. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8 (1999) 237-245
67. Ki C.S., Na D.L., Kim H.J., and Kim J.W. Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease. Neurosci Lett 302 (2001) 69-72
68. Kölsch H., Ptok U., Majores M., Schmitz S., Rao M.L., Maier W., et al. Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease. Psychiatric Genet 14 (2004) 97-100
69. Kolsch H., Ptok U., Mohamed I., Schmitz S., Rao M.L., Maier W., et al. Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am J Med Genet B: Neuropsychiatric Genet 121 (2003) 128-130
70. Korovaitseva G.I., Premkumar S., Grigorenko A., Molyaka Y., Galimbet V., Selezneva N., et al. Alpha-2 macroglobulin gene in early and late-onset Alzheimer disease. Neurosci Lett 271 (1999) 129-131
71. Koster M.N., Dermaut B., Cruts M., Houwing-Duistermaat J.J., Roks G., Tol J., et al. The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology 55 (2000) 678-684
72. Kovacs D.M. Alpha2-macroglobulin in late-onset Alzheimer's disease. Exp Gerontol 35 (2000) 473-479
73. Kovacs T., Cairns N.J., and Lantos P.L. Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci Lett 273 (1999) 61-83
74. Kuo H.C., Smith J.J., Lis A., Zhao L., Gonsiorek E.A., Zhou X., et al. Computer-identified nuclear localization signal in exon 1A of the transporter DMT1 is essentially ineffective in nuclear targeting. J Neurosci Res 76 (2004) 497-511
75. Lambert J.C., Wavrant-De Vrieze F., Amouyel P., and Chartier-Harlin M.C. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 351 (1998) 1787-1788
76. Lambert J.C., Chartier-Harlin M.C., Cottel D., Richard F., Neuman E., Guez D., et al. Is the LDL receptor-related protein involved in Alzheimer's disease?. Neurogenetics 2 (1999) 109-113
77. Lambert J.C., Goumidi L., Vrieze F.W., Frigard B., Harris J.M., Cummings A., et al. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 9 (2000) 2275-2280
78. Lambert J.C., Luedecking-Zimmer E., Merrot S., Hayes A., Thaker U., Desai P., et al. Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 40 (2003) 424-430
79. Lau K.F., Miller C.C., Anderton B.H., and Shaw P.C. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Genomics 60 (1999) 121-128
80. Lendon C.L., Talbot C.J., Craddock N.J., Han S.W., Wragg M., Morris J.C., et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 222 (1997) 187-190
81. Li D., and Mehta J.L. Upregulation of endothelial receptor for oxidized LDL [LOX-1] by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 20 (2000) 1116-1122
82. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S., Hinrichs A.L., et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 101 (2004) 15688-15693
83. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., et al. Genetic association of an alpha2-macroglobulin [Val1000lle] polymorphism and Alzheimer's disease. Hum Mol Genet 7 (1998) 1953-1956
84. Liu S.T., Howlett G., and Barrow C.J. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Biochemistry 38 (1999) 9373-9378
85. Llorca J., Dierssen-Sotos T., Combarros O., and Berciano J. Consistency in gene-Alzheimer's disease association studies. J Epidemiol Community Health 59 (2005) 83-85
86. Luedecking-Zimmer E., DeKosky S.T., Chen Q., Barmada M.M., and Kamboh M.I. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum Genet 111 (2002) 443-451
87. Luedecking-Zimmer E., DeKosky S.T., Nebes R., and Kamboh M.I. Association of the 3′-UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. Am J Med Genet :B Neuropsychiatric Genet 117 (2003) 114-117
88. Mayeux R., Lee J.H., Romas S.N., Mayo D., Santana V., Williamson J., et al. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Hum Genet 70 (2002) 237-243
89. McIlroy S.P., Dynan K.B., Vahidassr D.J., Lawson J.T., Patterson C.C., and Passmore P. Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in northern Ireland. Am J Med Genet 105 (2001) 502-506
90. Mehta J.L., and Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 39 (2002) 1429-1435
91. Myers A., Wavrant De-Vrieze F., Holmans P., Hamshere M., Crook R., Compton D., et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 114 (2002) 235-244
92. Myllykangas L., Polvikoski T., Sulkava R., Verkkoniemi A., Crook R., Tienari P.J., et al. Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann Neurol 46 (1999) 382-390
93. Nacmias B., Tedde A., Cellini E., Forleo P., Orlacchio A., Guarnieri B.M., et al. Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 299 (2001) 9-12
94. Narita M., Holtzman D.M., Schwartz A.L., and Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 69 (1997) 1904-1911
95. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347 (1996) 1091-1095
96. Nicosia F., Alberici A., Benussi L., Gasparini L., Ghidoni R., Mazzoli F., et al. Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer's disease. Dement Geriatr Cogn Disord 12 (2001) 305-308
97. Nowotny P., Li Y., Holmans P., Smemo S., Tacey K., Doil L., et al. Strong pattern of association with AD in a 210 kb region on chromosome 12. [Abstract 1848]. Proceedings of the 53rd Annual Meeting of The American Society of Human Genetics. Los Angeles, CA, USA (2003). http://www.ashg.org/genetics/abstracts/abs03/f1848.htm
98. Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., Capurso S., et al. Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease. Am J Med Genet B: Neuropsychiatric Genet 126 (2004) 69-73
99. Panza F., D'Introno A., Colacicco A.M., Capurso C., Basile A.M., Torres F., et al. LBP-1c/CP2/LSF gene polymorphism and risk of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 75 (2004) 166-168
100. Paromov V.M., and Morton R.E. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP). J Biol Chem 278 (2003) 40859-40866
101. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., et al. Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12. JAMA 278 (1997) 1237-1241
102. Perry R.T., Collins J.S., Harrell L.E., Acton R.T., and Go R.C. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 105 (2001) 332-342
103. Pirskanen M., Alafuzoff I., Hiltunen M., Mannermaa A., Helisalmi S., Lehtovirta M., et al. An association between a subset of Finnish late-onset Alzheimer's disease and alpha2-macroglobulin. Neurogenetics 3 (2001) 171-172
104. Poduslo S.E., and Yin X. Chromosome 12 and late-onset Alzheimer's disease. Neurosci Lett 310 (2001) 188-190
105. Poduslo S.E., Shook B., Drigalenko E., and Yin X. Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease. Am J Med Genet 110 (2002) 30-35
106. Prince J.A., Feuk L., Sawyer S.L., Gottfries J., Ricksten A., Nagga K., et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 9 (2001) 437-444
107. Pritchard A., St Clair D., Lemmon H., Mann D.M., and Lendon C. No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort. Neurosci Lett 366 (2004) 126-129
108. Pritchard A., Harris J., Pritchard C.W., St Clair D., Lemmon H., Lambert J.C., et al. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease. Neurosci Lett 382 (2005) 221-226
109. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
110. Rogaeva E., Premkumar S., Song Y., Sorbi S., Brindle N., Paterson A., et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280 (1998) 614-618
111. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., et al. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet 22 (1999) 19-22
112. Romas S.N., Mayeux R., Rabinowitz D., Tang M.X., Zadroga H.R., Lantigua R., et al. The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. Neurosci Lett 279 (2000) 133-136
113. Rosenmann H., Meiner Z., Kahana E., Aladjem Z., Friedman G., Ben-Yehuda A., et al. A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease. Neurosci Lett 336 (2003) 101-104
114. Rudrasingham V., Wavrant-DeVrieze F., Lambert J.C., Chakraverty S., Kehoe P., Crook R., et al. Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet 22 (1999) 17-19
115. Sanchez-Guerra M., Combarros O., Infante J., Llorca J., Berciano J., Fontalba A., et al. Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci Lett 316 (2001) 17-20
116. Saunders A.M., Strittmatter W.J., Schmechel D., St George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
117. Saunders A.J., Bertram L., Mullin K., Sampson A.J., Latifzai K., Basu S., et al. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum Mol Genet 12 (2003) 2765-2776
118. Sawa A., Khan A.A., Hester L.D., and Snyder S.H. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 94 (1997) 11669-11674
119. Scacchi R., Ruggeri M., Gambina G., Martini M.C., and Corbo R.M. Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease. Clin Chem Lab Med 40 (2002) 333-336
120. Schulze H., Schuler A., Stuber D., Dobeli H., Langen H., and Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J Neurochem 60 (1993) 1915-1922
121. Scott W.K., Yamaoka L.H., Bass M.P., Gaskell P.C., Conneally P.M., Small G.W., et al. No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease. Neurogenetics 1 (1998) 179-183
122. Scott W.K., Grubber J.M., Abou-Donia S.M., Church T.D., Saunders A.M., Roses A.D., et al. Further evidence linking late-onset Alzheimer disease with chromosome 12. JAMA 281 (1999) 513-514
123. Scott W.K., Grubber J.M., Conneally P.M., Small G.W., Hulette C.M., Rosenberg C.K., et al. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet 66 (2000) 922-932
124. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., et al. Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375 (1995) 754-760
125. Shibata N., Ohnuma T., Takahashi T., Ohtsuka E., Ueki A., and Arai H. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease. Neurosci Lett 271 (1999) 132-134
126. Shibata N., Ohnuma T., Takahashi T., Ohtsuka E., Ueki A., Nagao M., et al. No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease. Neurosci Lett 290 (2000) 154-156
127. Siffert W., Rosskopf D., Siffert G., Busch S., Moritz A., Erbel R., et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18 (1998) 45-48
128. Singleton A.B., Gibson A.M., McKeith I.G., Ballard C.A., Perry R.H., Ince P.G., et al. Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroreport 10 (1999) 1507-1510
129. Sleegers K., Roks G., Theuns J., Aulchenko Y.S., Rademakers R., Cruts M., et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain 127 (2004) 1641-1649
130. Sodeyama N., Yamada M., Itoh Y., Suematsu N., Matsushita M., Otomo E., et al. Alpha2-macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese. Neurology 54 (2000) 443-446
131. Soucek T., Cumming R., Dargusch R., Maher P., and Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39 (2003) 43-56
132. St. George-Hyslop P.H. Molecular genetics of Alzheimer disease. Semin Neurol 19 (1999) 371-383
133. Stanton K.C., Jiang L., Schnetz-Boutaud N., Kenealy S.J., Scott W.K., Schmidt S., et al. Further evidence of linkage of Alzheimer's disease on chromosome 12. Am J Hum Genet 73 Suppl (2003) 471 [Abstract]
134. Styczynska M., Religa D., Pfeffer A., Luczywek E., Wasiak B., Styczynski G., et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci Lett 344 (2003) 99-102
135. Tang G., Zhang M., Xie H., Jiang S., Wang Z., Xu L., et al. Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease. Neurosci Lett 328 (2002) 195-197
136. Taylor A.E., Yip A., Brayne C., Easton D., Evans J.G., Xuereb J., et al. Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet 38 (2001) 232-233
137. Tuppo E.E., and Arias H.R. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 37 (2005) 289-305
138. Van Leuven F., Thiry E., Lambrechts M., Stas L., Boon T., Bruynseels K., et al. Sequencing of the coding exons of the LRP1 and LDLR genes on individual DNA samples reveals novel mutations in both genes. Atherosclerosis 154 (2001) 567-577
139. Verpillat P., Bouley S., Hannequin D., Belliard S., Puel M., Thomas-Anterion C., et al. Alpa2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses. Ann Neurol 48 (2000) 400-402
140. Verpillat P., Bouley S., Campion D., Hannequin D., Dubois B., Belliard S., et al. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population. Eur J Hum Genet 9 (2001) 464-468
141. Wang X., Luedecking E.K., Minster R.L., Ganguli M., DeKosky S.T., and Kamboh M.I. Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. Hum Genet 108 (2001) 105-108
142. Wavrant-DeVrieze F., Perez-Tur J., Lambert J.C., Frigard B., Pasquier F., Delacourte A., et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 227 (1997) 68-70
143. Wavrant-DeVrieze F., Lambert J.C., Stas L., Crook R., Cottel D., Pasquier F., et al. Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum Genet 104 (1999) 432-434
144. Wavrant-DeVrieze F., Rudrasingham V., Lambert J.C., Chakraverty S., Kehoe P., Crook R., et al. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci Lett 262 (1999) 137-139
145. Woodward R., Singleton A.B., Gibson A.M., Edwardson J.A., and Morris C.M. LRP gene and late-onset Alzheimer's disease. Lancet 352 (1998) 239-240
146. Wu W.S., Holmans P., Wavrant-DeVrieze F., Shears S., Kehoe P., Crook R., et al. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 280 (1998) 619-622
147. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol 154 (1999) 927-936
148. Yoon J.B., Li G., and Roeder R.G. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro. Mol Cell Biol 14 (1994) 1776-1785
149. Zambrano N., Minopoli G., de Candia P., and Russo T. The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273 (1998) 20128-20133
150. Zappia M., Cittadella R., Manna I., Nicoletti G., Andreoli V., Bonavita S., et al. Genetic association of alpha2-macroglobulin polymorphisms with AD in southern Italy. Neurology 59 (2002) 756-758
151. Zappia M., Manna I., Serra P., Cittadella R., Andreoli V., and La Russa A. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms. Arch Neurol 6 (2004) 341-344
152. Zhang P., Yang Z., Wan C.L., Zheng W.D., Zhang C.F., and Li S. Neither the tumor necrosis factor alpha-308 A/G polymorphism nor the alpha2-macroglobulin polymorphism was associated with late-onset Alzheimer's disease in the Chinese population. Yi Chuan Xue Bao 31 (2004) 1-6
153. Zill P., Burger K., Behrens S., Hampel H., Padberg F., Boetsch T., et al. Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients. Neurosci Lett 294 (2000) 69-72
154. Zubenko G.S., Hughes H.B., Stiffler J.S., Hurtt M.R., and Kaplan B.B. A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. Genomics 50 (1998) 121-128
155. Zuliani G., and Hobbs H.H. Tetranucleotide length polymorphism 5′ of the alpha 2-macroglobulin receptor [A2MR]/LDL receptor-related protein [LRP] gene. Hum Mol Genet 3 (1994) 215
156. Xu J., Turner A., Little J., Bleecker E.R., and Meyers D.A. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error?. Hum Genet 111 (2002) 573-574